Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine

Clinical Pharmacology and Therapeutics

Volumn 70, Issue 4, 2001, Pages 344-350

  Jokinen, M J ^a   Olkkola, K T ^a   Ahonen, J ^a   Neuvonen, P J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; GESTODENE; LEVONORGESTREL; PLACEBO; RIFAMPICIN; ROPIVACAINE;

ADULT; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; ELECTROCARDIOGRAM; FEMALE; HUMAN; LIVER METABOLISM; MALE; PLASMA CLEARANCE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VENOUS BLOOD;

ADULT; AMIDES; ANESTHETICS, LOCAL; ANTIBIOTICS, ANTITUBERCULAR; AREA UNDER CURVE; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RIFAMPIN; SMOKING;

EID: 0034748799     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.118728     Document Type: Article

References (20)

1. Ropivacaine
2. Disposition kinetics of ropivacaine in humans
3. Metabolism and excretion of ropivacaine in humans
4. Metabolism of a local anesthetic, ropivacaine, by human hepatic cytochrome P450
5. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes
6. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
7. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine
8. Pharmacokinetic drug interactions with rifampin
9. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
10. Triazolam is ineffective in patients taking rifampin
11. Drug interactions with tobacco smoking. An update
12. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans
13. Determination of ropivacaine and [2H3]ropivacaine in biological samples by gas chromatography with nitrogen-phosphorus detection or mass spectrometry
14. Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column
15. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine
16. Update on rifampin drug interactions. III
17. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
18. Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo
19. Enzyme induction in the elderly: Effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone